• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
3,4-Dihydroxyphenyl Ethanol

3,4-Dihydroxyphenyl Ethanol

Product ID D3431
Cas No. 10597-60-1
Purity ≥95%
Product Unit SizeCostQuantityStock
10 mg $118.00 In stock
25 mg $225.30 In stock
100 mg $774.80 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

3,4-Dihydroxyphenol ethanol, also known as 3-hydroxytyrosol, is a polyphenol originally found in olive oil. 3-Hydroxytyrosol exhibits antioxidative, anti-inflammatory, anti-hyperlipidemic, anti-diabetic, anti-platelet, and anticancer chemotherapeutic activities. In brain slices undergoing hypoxia and reoxygenation, 3-hydroxytyrosol increases radical scavenging and glutathione activity and decreases lipid peroxidation and expression of prostaglandin E2 (PGE2) and IL-1β. 3-Hydroxytyrosol also decreases expression of prostaglandin E2 (PGE2), matrix metalloproteinase 9 (MMP9), and COX-2 through inhibition of PKC activation and NF-κB translocation. In animal models of diabetes, 3-hydroxytyrosol inhibits SREBP/Fas signaling to decrease lipid deposits and inhibits mitochondrial apoptosis, resulting in decreases in fasting glucose, serum lipid levels, and lipid oxidation. In whole blood and plasma, this compound inhibits platelet aggregation, inhibiting production of thromboxane B2, TNF-α, and leukocyte 6-keto-PGF1. Additionally, 3-hydroxytyrosol inhibits proliferation of cholangiocarcinoma cells in vitro and inhibits tumor growth of xenografts in vivo.

Product Info

Cas No.

10597-60-1

Purity

≥95%

Formula

C8H10O3

Formula Wt.

154.16

Chemical Name

2-(3,4-Dihydroxyphenyl)ethyl alcohol

IUPAC Name

4-(2-hydroxyethyl)benzene-1,2-diol

Synonym

3-Hydroxytyrosol

Solubility

Freely soluble in organic solvents. Slightly soluble in water (5 g/100 ml) at 25 oC.

Appearance

Light yellow viscous liquid

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

D3431 MSDS PDF

Info Sheet

D3431 Info Sheet PDF

References

Garcia-Molina G, Peters E, Palmeri R, et al. Enzymatic synthesis of hydroxytyrosol from oleuropein for valorization of an agricultural waste. Bioengineered. 2024 Dec;15(1):2396647. PMID: 39235136.

Scoditti E, Nestola A, Massaro M, et al. Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition. Atherosclerosis. 2014 Jan;232(1):17-24. PMID: 24401212.

Cao K, Xu J, Zou X, et al. Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radic Biol Med. 2013 Dec 6;67C:396-407. PMID: 24316371.

Li S, Han Z, Ma Y, et al. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: An in vivo and in vitro study. Oncol Rep. 2014 Jan;31(1):145-52. PMID: 24247752.

Cabrerizo S, De La Cruz JP, López-Villodres JA, et al. Role of the inhibition of oxidative stress and inflammatory mediators in the neuroprotective effects of hydroxytyrosol in rat brain slices subjected to hypoxia reoxygenation. J Nutr Biochem. 2013 Dec;24(12):2152-7. PMID: 24231104.

Correa JA, López-Villodres JA, Asensi R, et al. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid. Br J Nutr. 2009 Apr;101(8):1157-64. PMID: 18775097.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • R2788

    RGW-611

    Morpholine derivative.

    ≥98%
  • S336486

    Simeprevir

    NS3/4A inhibitor

    ≥99%
  • I5440

    INK128

    mTOR inhibitor.

    ≥99%
  • L1340

    LDK378

    ALK and IGF-1R inhibitor.

    ≥99%
  • G4532

    Gliclazide

    Sulfonylurea; SUR1 antagonist.

    ≥98%
  • A5287

    Angiotensinogen (1-14), human

    Peptide fragment, renin substrate, precursor to...

    ≥95%
  • D3372

    Disodium Cycloheptylaminomethylene Diphosphate

    Bisphosphonate; squalene synthase inhibitor.

    ≥98%
  • P8168

    Puromycin Dihydrochloride

    Protein synthesis inhibitor, DPP2 and metallope...

    ≥98%
  • N1983

    Neuropeptide Y (3-36), human

    Endogenous peptide neurotransmitter, involved i...

    ≥95%
  • R1776

    Resveratrol

    Phenolic phytoalexin found in soy, grapes, and ...

    ≥99%
  • C4800

    CM346 Hydrochloride

    Potential anxiolytic.

    ≥99%
  • A145823

    ADU-S100 sodium salt

    Synthetic cyclic dinucleotide agonist of STING....

    ≥99%
  • A480020

    (R,S)-AM 1241

    Cannabinoid receptor 2 selective agonist.

    ≥96%
  • P6865

    Propranolol Hydrochloride

    β1/2-adrenergic antagonist.

    ≥98%
  • N4974

    NMS-E628

    ALK and Ros1 inhibitor, Trk antagonist.

    ≥98%
  • E8419

    Everolimus

    mTORC1 inhibitor.

    ≥98%
  • V1854

    Venlafaxine Hydrochloride

    SERT, NET, MAO inhibitor.

    ≥98%
  • A7309

    Ascorbyl Palmitate

    Fat-soluble vitamin C derivative.

    ≥95%
  • T9969

    Tyrphostin AG490

    JAK2 inhibitor, potential EGFR inhibitor.

    ≥98%
  • C9613

    Cyclosporin D

    Cyclosporin metabolite; weak calmodulin inhibit...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only